Skip to content

PHARBEL: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARBEL

BE 0449.266.386
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€139,948
2024 · €413,138-€273,190
Equity
€1.3m
2024 · €1.3m+€49,948
Cash
€202,962
2024 · €381,572-€178,610
Balance sheet total
€2.8m
2024 · €3.2m-€378,753

Largest movements

2024 to 2025
Assets
  • Cash -€178,610

    down €178,610 (-46.8%), from €381,572 to €202,962

    mainly Trade debts (-€314,020) and Contributions, distributions and other (-€90,000)

  • Stocks and contracts -€114,317

    down €114,317 (-20.1%), from €568,730 to €454,413

  • Tangible fixed assets -€103,996

    down €103,996 (-5.3%), from €2.0m to €1.9m

    of which Plant, machinery and equipment: -€72,490

Equity and liabilities
  • Trade debts -€314,020

    down €314,020 (-69.5%), from €451,506 to €137,486

  • Other debts -€62,434

    down €62,434 (-10.7%), from €585,574 to €523,140

  • Reserves +€49,000

    up €49,000 (+6.0%), from €810,560 to €859,560

    of which Distributable reserves: +€49,000

  • Debts after one year -€47,687

    down €47,687 (-6.1%), from €783,345 to €735,658

Income statement
  • Gross operating margin -€352,273

    down €352,273 (-25.5%), from €1.4m to €1.0m

  • Taxes -€127,867

    down €127,867 (-65.3%), from €195,787 to €67,920

  • Write-downs +€122,431

    new in 2025: €122,431

  • Staff costs -€56,552

    down €56,552 (-10.1%), from €558,233 to €501,681

  • Financial charges -€19,910

    down €19,910 (-27.3%), from €72,859 to €52,949

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €413,138
Gross operating margin -€352,273
Staff costs +€56,552
Depreciation -€2,815
Write-downs -€122,431
Financial charges +€19,910
Taxes +€127,867
Result 2025 €139,948

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€575
Investment -€40,798
Financing -€137,237
Cash 2024 €381,572
Net result for the year +€139,948
Depreciation +€144,794
Stocks and contracts +€114,317
Receivables within one year -€18,170
Trade debts -€314,020
Tax, wage and social debts -€5,010
Other debts -€62,434
Investment in fixed assets (net) -€40,798
Debts after one year -€47,687
Current portion of long-term debt +€450
Contributions, distributions and other -€90,000
Cash 2025 €202,962
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,213,316 €2,834,563 -€378,753 -11.8%
Fixed assets 21/28 €1,960,951 €1,856,954 -€103,996 -5.3%
Tangible fixed assets 22/27 €1,960,720 €1,856,724 -€103,996 -5.3%
Land and buildings 22 €1,376,555 €1,337,421 -€39,135 -2.8%
Plant, machinery and equipment 23 €490,330 €417,840 -€72,490 -14.8%
Furniture and vehicles 24 €93,835 €101,463 +€7,628 +8.1%
Financial fixed assets 28 €230 €230 = 0.0%
Current assets 29/58 €1,252,366 €977,608 -€274,757 -21.9%
Stocks and contracts in progress 3 €568,730 €454,413 -€114,317 -20.1%
Stocks 30/36 €568,730 €454,413 -€114,317 -20.1%
Amounts receivable within one year 40/41 €302,064 €320,234 +€18,170 +6.0%
Trade receivables 40 €232,841 €260,764 +€27,923 +12.0%
Other amounts receivable 41 €69,223 €59,470 -€9,753 -14.1%
Cash at bank and in hand 54/58 €381,572 €202,962 -€178,610 -46.8%
Total equity and liabilities 10/49 €3,213,316 €2,834,563 -€378,753 -11.8%
Equity 10/15 €1,276,145 €1,326,093 +€49,948 +3.9%
Contributions 10/11 €235,598 €235,598 = 0.0%
Capital 10 €235,598 €235,598 = 0.0%
Issued capital 100 €235,598 €235,598 = 0.0%
Reserves 13 €810,560 €859,560 +€49,000 +6.0%
Non-distributable reserves 130/1 €23,560 €23,560 = 0.0%
Legal reserve 130 €23,560 €23,560 = 0.0%
Distributable reserves 133 €787,000 €836,000 +€49,000 +6.2%
Profit (loss) carried forward 14 €229,987 €230,935 +€948 +0.4%
Amounts payable 17/49 €1,937,171 €1,508,469 -€428,702 -22.1%
Amounts payable after more than one year 17 €783,345 €735,658 -€47,687 -6.1%
Financial debts 170/4 €783,345 €735,658 -€47,687 -6.1%
Amounts payable within one year 42/48 €1,153,826 €772,812 -€381,014 -33.0%
Current portion of amounts payable after more than one year 42 €47,237 €47,687 +€450 +1.0%
Trade debts 44 €451,506 €137,486 -€314,020 -69.5%
Suppliers 440/4 €451,506 €137,486 -€314,020 -69.5%
Taxes, remuneration and social security 45 €69,509 €64,499 -€5,010 -7.2%
Taxes 450/3 €15,512 €19,822 +€4,310 +27.8%
Remuneration and social security 454/9 €53,997 €44,677 -€9,320 -17.3%
Other amounts payable 47/48 €585,574 €523,140 -€62,434 -10.7%
Non-recurring operating income 76A €295,647 €156 -€295,491 -99.9%
Remuneration, social security and pensions 62 €558,233 €501,681 -€56,552 -10.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €141,979 €144,794 +€2,815 +2.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €122,431 +€122,431
Gross operating margin 9900 €1,381,996 €1,029,723 -€352,273 -25.5%
Operating profit (loss) 9901 €681,785 €260,817 -€420,967 -61.7%
Financial charges 65/66B €72,859 €52,949 -€19,910 -27.3%
Recurring financial charges 65 €72,859 €52,949 -€19,910 -27.3%
Profit (loss) for the period before taxes 9903 €608,926 €207,868 -€401,057 -65.9%
Income taxes 67/77 €195,787 €67,920 -€127,867 -65.3%
Profit (loss) for the period 9904 €413,138 €139,948 -€273,190 -66.1%
Profit (loss) for the period to be appropriated 9905 €413,138 €139,948 -€273,190 -66.1%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.